CBMT-05. GENETIC AND EPIGENETIC MECHANISMS REGULATING SCD INHIBITOR SENSITIVITY IN GLIOBLASTOMA

A status-quo in targeted cancer therapy is that out of the thousands of somatic alterations found in a cancer cell, alterations only in driver genes determine therapeutic strategy. Despite unimpressive results of some driver-targeted therapies, and given that the majority of genomic alterations in c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Oatman, Nicole, Dasgupta, Nupur, Dasgupta, Biplab, Choi, Kwangmin, Gawali, Mruniya, Gupta, Nishtha, Parameswaran, Sreeja, Lawler, Sean, Brennan, Cameron, Wu, Jianqiang, Sallans, Larry, Desai, Pankaj, Weirauch, Matthew, Komurov, Kakajan
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
Cell Biology and Metabolism
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847859/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.127
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares